-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Kairos Pharma, LTD. quarterly/annual Nonoperating Income (Expense) history and change rate from Q3 2023 to Q3 2025.
- Kairos Pharma, LTD. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $37K.
- Kairos Pharma, LTD. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $546K.
- Kairos Pharma, LTD. annual Nonoperating Income (Expense) for 2024 was -$260K, a 165% decline from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)